Cochrane's Strategy for Change, our strategic plan that will guide us to make the changes we need to make in 2021-2023 to remain sustainable, is based on extensive consultation with the Cochrane Community and on our previous strategic plan, Strategy to 2020. This page tells the story of the Strategy to 2020.

In October 2013, Cochrane celebrated 20 years of its international health evidence collaboration. The organization had grown over the prior two decades to become a leader in synthesizing evidence to inform health decisions, with contributions from supporters all around the globe. To carry Cochrane forward beyond this moment, we established the Strategy to 2020, an organizational strategic plan that would guide the work we have undertaken in the past seven years.

Strategy to 2020 aimed to achieve four key Goals: structured as three interlocking areas of equal focus and priority (Goals 1-3), underpinned by a fourth foundational area (Goal 4) designed to strengthen the organization and support our mission:

GOAL 1: Producing evidence

To produce high-quality, relevant, up-to-date systematic reviews, and other synthesized research evidence to inform health decision making.

GOAL 2: Making our evidence accessible

To make Cochrane evidence accessible and useful to everybody, everywhere in the world.

GOAL 3: Advocating for evidence

To make Cochrane the ‘home of evidence' to inform health decision making, build greater recognition of our work, and become the leading advocate for evidence-informed health care.

GOAL 4: Building an effective sustainable organization

To be a diverse, inclusive, and transparent international organization that effectively harnesses the enthusiasm and skills of our contributors, is guided by our principles, governed accountably, managed efficiently, and makes optimal use of its resources.